Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90% - cnbc.com
- Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90% cnbc.com
- Moderna shares surge as melanoma vaccine with Merck succeeds in large trial CNN
- Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial STAT
- Moderna’s stock doubles on promising cancer-vaccine results marketwatch.com
- Cancer treatment could face landmark moment with promising vaccine The Washington Post
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events